Carcinoid Syndrome Management Market 2019 Global Industry Analysis Size and SharPosted by shriya on June 11th, 2021 Global Carcinoid Syndrome Management Market Information, by organs affected (Small Intestine, Lungs, Rectum, Appendix, Colon, Stomach, Pancreas, Liver and others) by Treatment (Chemotherapy, Biological therapy, and Hepatic Artery Embolization Agents), by End users (Hospital, Clinics, Cancer institute and treatment centers) Forecast to 2027 Carcinoid syndrome is the aftermath which occurs after carcinoid tumors. Signs of the syndrome include unexplained weight gain, sweating, fast heartbeat, intestinal bleeding, vasoconstriction, and shortness of breath. A combination of palliative and supportive care is required for controlling the syndrome. Market Research Future (MRFR) outlines various trends and opportunities in the global carcinoid syndrome management market which estimate an accurate market valuation. Market Outlook The global carcinoid syndrome management market is poised for a meteoric valuation with a high growth rate between 2017 and 2022 (forecast period). Rising incidence of hormonal disorders, high levels of carcinogens, and unbreakable smoking habits are factors which can drive the market growth. As per the National Institute of Health, incidence of carcinoid tumor is reportedly 2 for every 100,000 with the possibility of tumor in the gastrointestinal (GI) tract. Surgical options for removal or elimination of carcinoid tumors can also be one of the biggest drivers of the market. Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/carcinoid-syndrome-management-market-2843 Contact: Akash Anand Market Research Future +1 646 845 9312 Like it? Share it! More by this author |